HFCP X (Parallel-A), L.P. 4

What Happened
Hellman & Friedman Capital Partners X (Parallel), L.P., a reported 10% owner of Medline Inc. (MDLN), disposed of a block of Class A common stock on March 10, 2026. The filing shows sales of 26,131,237 shares at an effective price of $40.51 per share (net of underwriting discount), generating approximately $1.06 billion in proceeds. Additional disposition-type entries (code J) reflect transfers/distributions of smaller share blocks to related entities/partners (amounts and values shown as N/A in the filing).

Key Details

• Transaction date: March 10, 2026; Form 4 filed March 12, 2026 (appears timely).
• Sales reported (all code S unless noted):
  • 14,639,754 shares @ $40.51 = $593,027,155
  • 629,933 shares @ $40.51 = $25,517,326
  • 9,801,455 shares @ $40.51 = $397,037,339
  • 1,060,095 shares @ $40.51 = $42,942,328
  • Plus three "other disposition" entries (codes J) covering 538,997; 1,435,395; and 113,694 shares (values N/A).
• Net price basis: The $40.51 reflects the $41.00 offering price less an underwriting discount (see footnote).
• Shares owned after transaction: Not specified in this Form 4.
• Notable footnotes: sales were part of an underwritten secondary offering; certain shares were contributed to subsidiaries that sold in the offering; in-kind distributions were made to partners/shareholders and recipients agreed to underwriter lock‑ups (charitable gifts <1% excepted). Reporting persons disclaim beneficial ownership except to the extent of pecuniary interest.

Context

• This is institutional selling by a large private-equity investor in a secondary public offering, not a routine open-market trade by a company insider. The J-code entries reflect related-entity transfers and in-kind distributions rather than new purchases.
• Such large institutional dispositions often reflect liquidity/event-related transactions (e.g., secondary offering and partner distributions) and should not be read as direct managerial sentiment about the company.